IP Library › Patent Application 18108148
Patent Application
App. No. 18/108,148

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/108,148
Abstract

The present invention relates generally to immunization and immunotherapy for the treatment or prevention of HIV. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.

Claims (3)

1 . A lentiviral vector comprising at least one encoded genetic element, wherein the at least one encoded genetic element comprises

at least two of: (i) a sequence comprising at least 80% sequence identity with SEQ ID NO: 1, (ii) a sequence comprising at least 80% sequence identity with SEQ ID NO: 2, and (iii) a sequence comprising at least 80% sequence identity with SEQ ID NO: 3; or

any two of: (iv) a sequence comprising at least 80% sequence identity with SEQ ID NO: 97, (v) a sequence comprising at least 80% sequence identity with SEQ ID NO: 6, and (vi) a sequence comprising at least 80% sequence identity with SEQ ID NO: 7.

Assignments (2)
SECURITY INTEREST Recorded Nov 8, 2023
From: AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 065521/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2023
From: PAUZA, CHARLES DAVID; LI, HAISHAN; LAHUSEN, TYLER; GALVIN, JEFF
To: AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
Reel/Frame 062652/0183 →